Ads
-
Related paper
- MicroRNA: New Era for Therapeutic Strategy in Ischaemic Heart Disease
- Problems of diagnosis and treatment of chronic ischaemic heart disease combined with chronic obstructive pulmonary disease according to retrospective analysis
- ANAEMIA AND ELEVATED LEUCOCYTE COUNT AS A RISK FACTOR FOR ISCHAEMIC HEART DISEASE
- Refractory Hypotension Following Sublingual Isosorbide Dinitrate in the Postoperative Period in a Patient with Ischaemic Heart Disease
- The role of endothelin-1 and nitric oxide affecting endothelial dysfunction in the etiopathogenesis of ischaemic heart disease
- Physical Activity And Risk Factors Screening For Ischaemic Heart Disease In South African Individuals Living With HIV
- Remodeling of heart in patients with stable ischemic heart disease combined with chronic obstructive pulmonary disease as a basis for development of heart failure
- Features of Heart Rate Variability in Patients with Coronary Heart Disease and Risk Factors for Cardiovascular Disease According to the SCORE Charts in the Presence of Heart Rate Turbulence
- Effect of cardioactive principle of methanolic extract of Allium humile leaves on global ischaemic rat heart
- Comparative Study of Urine Albumin Creatinine Ratio v/s Intima Media Thickening as a Marker of Atherogenicity in Ischaemic Heart Diseases